{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:24:10Z","timestamp":1788269050238,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several grading methods had been proposed for pulmonary adenocarcinomas in the past decades. We aimed to evaluate and compare the prognostic performance of these grading schemes on overall survival (OS) and recurrence-free survival (RFS) in a single center study. Our retrospective study included patients diagnosed with lung adenocarcinoma who underwent surgery between 2010 and 2016 at the clinic of Szeged. Morphological patterns were recorded and revised on histological slides. As statistical analyses, Cox proportional hazard models, Kaplan-Meier analyses, log rank test and ROC analyses were applied. Altogether 304 patients were included in our study. In multivariate analysis of OS, type of surgery (HR:1.81, 95%CI:1.08\u20133.02, p\u2009=\u20090.025), architectural grade combined with spread through air spaces (STAS) (HR:4.38, 95%CI:1.88\u201310.20, p\u2009&lt;\u20090.001), lymphovascular (HR:1.87, 95%CI:1.13\u20133.09, p\u2009=\u20090.014), and vascular spread (HR:2.07, 95%CI:1.00-4.25, p\u2009=\u20090.049) were independent prognostic factors. In multivariate analysis of RFS, stage (HR:2.84, 95%CI:1.42\u20135.67, p\u2009=\u20090.003) architectural grade combined with STAS (HR:3.13, 95%CI:1.70\u20135.32, p\u2009&lt;\u20090.010) and vascular spread (HR:2.42, 95%CI:1.31\u20134.48, p\u2009=\u20090.005) proved to be independent prognosticators. In a subgroup analysis excluding the adverse factors the architectural grade combined with STAS preserved its prognostic impact on OS and RFS. Most grading systems of pulmonary adenocarcinoma take into consideration the architectural features; however, some of them focus on nuclear features or STAS. We have compared the available grading systems and have proven that almost all of them have prognostic role on survival. The architectural grade combined with STAS was superior to others even in subgroup analysis where adverse factors were omitted.<\/jats:p>","DOI":"10.1007\/s00428-026-04707-8","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:11:30Z","timestamp":1788268290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of grading systems among pulmonary adenocarcinomas: architectural grade combined with STAS is superior to others - a single centre study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-3633","authenticated-orcid":false,"given":"Fanni","family":"Heged\u0171s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6021-9035","authenticated-orcid":false,"given":"Zs\u00f3fia Eszter","family":"Sz\u00e9ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0386-3464","authenticated-orcid":false,"given":"Daniella","family":"R\u00f3zsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-6307","authenticated-orcid":false,"given":"No\u00e9mi","family":"Zombori-T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7224-1642","authenticated-orcid":false,"given":"J\u00f3zsef","family":"Fur\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-6587","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"Tiszlavicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-563X","authenticated-orcid":false,"given":"Tam\u00e1s","family":"Zombori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"4707_CR1","volume-title":"World Cancer Report 2008","author":"P Boyle","year":"2010","unstructured":"Boyle P, Levin B (2010) World Cancer Report 2008. International Agency for Research on Cancer, Lyon"},{"key":"4707_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108. https:\/\/doi.org\/10.3322\/canjclin.55.2.74","journal-title":"CA Cancer J Clin"},{"key":"4707_CR3","volume-title":"Cancer Incidence in Five Continents","author":"MP Curado","year":"2007","unstructured":"Curado MP, Edwards B, Shin HR et al (2007) Cancer Incidence in Five Continents. IX. IARC Scientific, Lyon"},{"key":"4707_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41379-021-00934-3","volume":"35","author":"AC Borczuk","year":"2022","unstructured":"Borczuk AC (2022) Updates in grading and invasion assessment in lung adenocarcinoma. Mod Pathol 35:28\u201335. https:\/\/doi.org\/10.1038\/s41379-021-00934-3","journal-title":"Mod Pathol"},{"key":"4707_CR5","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s12253-020-00855-7","volume":"26","author":"T Zombori","year":"2020","unstructured":"Zombori T, Sejben A, Tiszlavicz L, Cserni G, P\u00e1lf\u00f6ldi R, Csada E, Fur\u00e1k J (2020) Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas. Pathol Oncol Res 26:2451\u20132458. https:\/\/doi.org\/10.1007\/s12253-020-00855-7","journal-title":"Pathol Oncol Res"},{"key":"4707_CR6","volume-title":"AJCC cancer staging manual (8th edition)","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual (8th edition). Springer International Publishing, New York"},{"key":"4707_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.humpath.2019.09.006","volume":"94","author":"K Rabe","year":"2019","unstructured":"Rabe K, Snir OL, Bossuyt V, Harigopal M, Celli R, Reisenbichler ES (2019) Interobserver variability in breast carcinoma grading results in prognostic stage differences. Hum Pathol 94:51\u201357. https:\/\/doi.org\/10.1016\/j.humpath.2019.09.006","journal-title":"Hum Pathol"},{"key":"4707_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12253-015-0013-x","volume":"22","author":"B Helpap","year":"2016","unstructured":"Helpap B, Ringli D, Tonhauser J, Poser I, Breul J, Gevensleben H, Seifert HH (2016) The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer. Pathol Oncol Res 22:349\u2013356. https:\/\/doi.org\/10.1007\/s12253-015-0013-x","journal-title":"Pathol Oncol Res"},{"key":"4707_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5858\/arpa.2019-0551-RA","volume":"144","author":"T Rice-Stitt","year":"2020","unstructured":"Rice-Stitt T, Valencia-Guerrero A, Cornejo KM, Wu CL (2020) Updates in Histologic Grading of Urologic Neoplasms. Arch Pathol Lab Med 144:335\u2013343. https:\/\/doi.org\/10.5858\/arpa.2019-0551-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4707_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis WD, Brambilla E, Noguchi M et al (2011) International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244\u2013285. https:\/\/doi.org\/10.1097\/JTO.0b013e318206a221","journal-title":"J Thorac Oncol"},{"key":"4707_CR11","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/PAS.0b013e3181e4ee32","volume":"34","author":"G Sica","year":"2010","unstructured":"Sica G, Yoshizawa A, Sima CS, Azzoli CG, Downey RJ, Rusch VW, Travis WD, Moreira AL (2010) A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 34:1155\u20131162. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e4ee32","journal-title":"Am J Surg Pathol"},{"key":"4707_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/modpathol.2012.58","volume":"25","author":"K Kadota","year":"2012","unstructured":"Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD (2012) A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 25:1117\u20131127. https:\/\/doi.org\/10.1038\/modpathol.2012.58","journal-title":"Mod Pathol"},{"key":"4707_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00432-019-03110-y","volume":"146","author":"DH Liu","year":"2020","unstructured":"Liu DH, Ye ZH, Chen S, Sun XS, Hou JY, Zhao ZR, Long H (2020) Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients. J Cancer Res Clin Oncol 146:801\u2013807. https:\/\/doi.org\/10.1007\/s00432-019-03110-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"4707_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira AL, Ocampo PSS, Xia Y et al (2020) A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol 15:1599\u20131610. https:\/\/doi.org\/10.1016\/j.jtho.2020.06.001","journal-title":"J Thorac Oncol"},{"key":"4707_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/his.15172","volume":"85","author":"F Heged\u0171s","year":"2024","unstructured":"Heged\u0171s F, Zombori-T\u00f3th N, Kiss S, Lantos T, Zombori T (2024) Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis. Histopathology 85:51\u201361. https:\/\/doi.org\/10.1111\/his.15172","journal-title":"Histopathology"},{"key":"4707_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/PAS.0000000000002040","volume":"47","author":"Y Boss\u00e9","year":"2023","unstructured":"Boss\u00e9 Y, Gagn\u00e9 A, Althakfi WA, Orain M, Couture C, Trahan S, Pag\u00e9 S, Joubert D, Fiset PO, Desmeules P, Joubert P (2023) A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination. Am J Surg Pathol 47:686\u2013693. https:\/\/doi.org\/10.1097\/PAS.0000000000002040","journal-title":"Am J Surg Pathol"},{"key":"4707_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/1759-7714.15204","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Li Y, Sun X, Dong J, Liu L, Liu J, Chen R, Li F, Chen T, Li X, Xie G, Ying J, Guo Q, Mao Y, Yang L (2024) Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thorac Cancer 15:519\u2013528. https:\/\/doi.org\/10.1111\/1759-7714.15204","journal-title":"Thorac Cancer"},{"key":"4707_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jclinpath-2020-207104","volume":"75","author":"JH Qiu","year":"2022","unstructured":"Qiu JH, Hu GM, Zhang RZ, Hu M, Li Z, Zhang Y, Wu HF, Fu WJ, Zhang M, Feng YK, Niu L, Ren JL (2022) Optimised architecture-based grading system as an independent prognostic factor in resected lung adenocarcinoma. J Clin Pathol 75:176\u2013184. https:\/\/doi.org\/10.1136\/jclinpath-2020-207104","journal-title":"J Clin Pathol"},{"key":"4707_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000525456","volume":"90","author":"N Zombori-T\u00f3th","year":"2023","unstructured":"Zombori-T\u00f3th N, Par\u00f3czai D, Lantos J, Alm\u00e1si S, Sejben A, Tiszlavicz L, Cserni G, Fur\u00e1k J, Zombori T (2023) The More Extensive the Spread through Air Spaces, the Worse the Prognosis Is: Semi-Quantitative Evaluation of Spread through Air Spaces in Pulmonary Adenocarcinomas. Pathobiology 90:104\u2013113. https:\/\/doi.org\/10.1159\/000525456","journal-title":"Pathobiology"},{"key":"4707_CR20","volume-title":"Thoracic tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021","unstructured":"WHO Classification of Tumours Editorial Board (2021) Thoracic tumours. International Agency for Research on Cancer, Lyon"},{"key":"4707_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JTO.0000000000000486","volume":"10","author":"K Kadota","year":"2015","unstructured":"Kadota K, Nitadori JI, Sima CS, Ujiie H, Rizk NP, Jones DR, Adusumilli PS, Travis WD (2015) Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas. J Thorac Oncol 10:806\u2013814. https:\/\/doi.org\/10.1097\/JTO.0000000000000486","journal-title":"J Thorac Oncol"},{"key":"4707_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/his.14062","volume":"77","author":"AR Shih","year":"2020","unstructured":"Shih AR, Mino-Kenudson M (2020) Updates on spread through air spaces (STAS) in lung cancer. Histopathology 77:173\u2013180. https:\/\/doi.org\/10.1111\/his.14062","journal-title":"Histopathology"},{"key":"4707_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"4707_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0003-4975(10)60819-3","volume":"33","author":"CK Chung","year":"1982","unstructured":"Chung CK, Zaino R, Stryker JA, O\u2019Neill M Jr, DeMuth WE Jr (1982) Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. Ann Thorac Surg 33:599\u2013604. https:\/\/doi.org\/10.1016\/s0003-4975(10)60819-3","journal-title":"Ann Thorac Surg"},{"key":"4707_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/JTO.0b013e31814617c7","volume":"2","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Toyooka S, Soh J, Ichimura K, Yanai H, Suehisa H, Ichihara S, Yamane M, Aoe M, Sano Y, Date H (2007) Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20\u00a0mm or less. J Thorac Oncol 2:808\u2013812. https:\/\/doi.org\/10.1097\/JTO.0b013e31814617c7","journal-title":"J Thorac Oncol"},{"key":"4707_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/cncr.24948","volume":"116","author":"Y Nakazato","year":"2010","unstructured":"Nakazato Y, Minami Y, Kobayashi H, Satomi K, Anami Y, Tsuta K, Tanaka R, Okada M, Goya T, Noguchi M (2010) Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer 116:2011\u20132019. https:\/\/doi.org\/10.1002\/cncr.24948","journal-title":"Cancer"},{"key":"4707_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.lungcan.2008.12.013","volume":"65","author":"I Petersen","year":"2009","unstructured":"Petersen I, Kotb WF, Friedrich KH, Schl\u00fcns K, B\u00f6cking A, Dietel M (2009) Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 65:312\u2013318. https:\/\/doi.org\/10.1016\/j.lungcan.2008.12.013","journal-title":"Lung Cancer"},{"key":"4707_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/modpathol.2010.232","volume":"24","author":"A Yoshizawa","year":"2011","unstructured":"Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD (2011) Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24:653\u2013664. https:\/\/doi.org\/10.1038\/modpathol.2010.232","journal-title":"Mod Pathol"},{"key":"4707_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2559.2004.01946.x","volume":"45","author":"S Aida","year":"2004","unstructured":"Aida S, Shimazaki H, Sato K, Sato M, Deguchi H, Ozeki Y, Tamai S (2004) Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types. Histopathology 45:468\u2013476. https:\/\/doi.org\/10.1111\/j.1365-2559.2004.01946.x","journal-title":"Histopathology"},{"key":"4707_CR30","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.athoracsur.2006.01.021","volume":"81","author":"M Riquet","year":"2006","unstructured":"Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C (2006) Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg 81:1988\u20131995. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.01.021","journal-title":"Ann Thorac Surg"},{"key":"4707_CR31","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2015","unstructured":"Travis WD, World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology (2015) WHO classification of tumours of the lung, pleura, thymus and heart. IARC, Oxford University Press, Lyon and Oxford"},{"key":"4707_CR32","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","volume":"30","author":"A Warth","year":"2012","unstructured":"Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W (2012) The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438\u20131446. https:\/\/doi.org\/10.1200\/JCO.2011.37.2185","journal-title":"J Clin Oncol"},{"key":"4707_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JTO.0b013e3182769aa8","volume":"8","author":"A Yoshizawa","year":"2013","unstructured":"Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, Tsuruyama T, Travis WD, Date H, Haga H (2013) Validation of the IASLC\/ATS\/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 8:52\u201361. https:\/\/doi.org\/10.1097\/JTO.0b013e3182769aa8","journal-title":"J Thorac Oncol"},{"key":"4707_CR34","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.cllc.2016.03.009","volume":"17","author":"M Behera","year":"2016","unstructured":"Behera M, Owonikoko TK, Gal AA, Steuer CE, Kim S, Pillai RN, Khuri FR, Ramalingam SS, Sica GL (2016) Lung Adenocarcinoma Staging Using the 2011 IASLC\/ATS\/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma. Clin Lung Cancer 17:e57\u2013e64. https:\/\/doi.org\/10.1016\/j.cllc.2016.03.009","journal-title":"Clin Lung Cancer"},{"key":"4707_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00000478-200301000-00011","volume":"27","author":"T Miyoshi","year":"2003","unstructured":"Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E, Ishikawa Y (2003) Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 27:101\u2013109. https:\/\/doi.org\/10.1097\/00000478-200301000-00011","journal-title":"Am J Surg Pathol"},{"key":"4707_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/modpathol.2008.79","volume":"21","author":"K Kamiya","year":"2008","unstructured":"Kamiya K, Hayashi Y, Douguchi J, Hashiguchi A, Yamada T, Izumi Y, Watanabe M, Kawamura M, Horinouchi H, Shimada N, Kobayashi K, Sakamoto M (2008) Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol 21:992\u20131001. https:\/\/doi.org\/10.1038\/modpathol.2008.79","journal-title":"Mod Pathol"},{"key":"4707_CR37","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00428-018-2337-x","volume":"472","author":"T Zombori","year":"2018","unstructured":"Zombori T, Ny\u00e1ri T, Tiszlavicz L, P\u00e1lf\u00f6ldi R, Csada E, G\u00e9czi T, Ottlak\u00e1n A, P\u00e9csy B, Cserni G, Fur\u00e1k J (2018) The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides. Virchows Arch 472:949\u2013958. https:\/\/doi.org\/10.1007\/s00428-018-2337-x","journal-title":"Virchows Arch"},{"key":"4707_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.prp.2013.09.016","volume":"210","author":"A Ambrosini-Spaltro","year":"2014","unstructured":"Ambrosini-Spaltro A, Ruiu A, Seebacher C, Vattemi E, Gentile L, Feil B, Zaraca F, Carella R (2014) Impact of the IASLC\/ATS\/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analyses. Pathol Res Pract 210:40\u201346. https:\/\/doi.org\/10.1016\/j.prp.2013.09.016","journal-title":"Pathol Res Pract"},{"key":"4707_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jclinpath-2016-204302","volume":"71","author":"T Zombori","year":"2018","unstructured":"Zombori T, Fur\u00e1k J, Ny\u00e1ri T, Cserni G, Tiszlavicz L (2018) Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study. J Clin Pathol 71:135\u2013140. https:\/\/doi.org\/10.1136\/jclinpath-2016-204302","journal-title":"J Clin Pathol"},{"key":"4707_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lungcan.2017.04.013","volume":"109","author":"JM Boland","year":"2017","unstructured":"Boland JM, Wampfler JA, Yang P, Yi ES (2017) Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis. Lung Cancer 109:14\u201320. https:\/\/doi.org\/10.1016\/j.lungcan.2017.04.013","journal-title":"Lung Cancer"},{"key":"4707_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/PAS.0000000000000409","volume":"39","author":"A Warth","year":"2015","unstructured":"Warth A, Muley T, Kossakowski CA, Goeppert B, Schirmacher P, Dienemann H, Weichert W (2015) Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma. Am J Surg Pathol 39:793\u2013801. https:\/\/doi.org\/10.1097\/PAS.0000000000000409","journal-title":"Am J Surg Pathol"},{"key":"4707_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41379-020-00709-2","volume":"34","author":"YB Han","year":"2021","unstructured":"Han YB, Kim H, Mino-Kenudson M, Cho S, Kwon HJ, Lee KR, Kwon S, Lee J, Kim K, Jheon S, Lee CT, Lee JS, Kook W, Chung JH (2021) Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer. Mod Pathol 34:549\u2013561. https:\/\/doi.org\/10.1038\/s41379-020-00709-2. Erratum in: Mod Pathol. 2021;34(5):1038. doi: 10.1038\/s41379-021-00748-3. PMID: 33199839","journal-title":"Mod Pathol"},{"key":"4707_CR43","doi-asserted-by":"publisher","first-page":"152598","DOI":"10.1016\/j.anndiagpath.2025.152598","volume":"81","author":"SEP \u00dcnal","year":"2026","unstructured":"\u00dcnal SEP, Sadullaho\u011flu C, Ye\u015fil\u00e7ay HB, Akda\u011f \u015e (2026) Spread through air spaces (STAS) in lung adenocarcinoma: Prognostic impact of morphologic patterns, density, and extent. Ann Diagn Pathol 81:152598. https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152598","journal-title":"Ann Diagn Pathol"},{"key":"4707_CR44","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1183\/09031936.00219211","volume":"40","author":"A Warth","year":"2012","unstructured":"Warth A, Stenzinger A, von Br\u00fcnneck AC, Goeppert B, Cortis J, Petersen I, Hoffmann H, Schnabel PA, Weichertet W (2012) Interobserver variability in the application of the novel IASLC\/ATS\/ERS classification for pulmonary adenocarcinomas. Eur Respir J 40:1221\u20131227. https:\/\/doi.org\/10.1183\/09031936.00219211","journal-title":"Eur Respir J"},{"key":"4707_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00428-012-1263-6","volume":"461","author":"A Warth","year":"2012","unstructured":"Warth A, Cortis J, Fink L, Fisseler-Eckhoff A, Geddert H, Hager T, Junker K, Kayser G, Kitz J, L\u00e4nger F, Morresi-Hauf A, Ott G, Petersen I, Stenzinger A, Soltermann A, Ting S, Tischler V, Vollmer E, Schnabel PA, Weichert W (2012) Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC\/ATS\/ERS classification. Virchows Arch 461:185\u2013193. https:\/\/doi.org\/10.1007\/s00428-012-1263-6","journal-title":"Virchows Arch"},{"key":"4707_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000525456","volume":"90","author":"N Zombori-T\u00f3th","year":"2023","unstructured":"Zombori-T\u00f3th N, Par\u00f3czai D, Lantos J, Alm\u00e1si S, Sejben A, Tiszlavicz L, Cserni G, Fur\u00e1k J, Zombori T (2023) The More Extensive the Spread through Air Spaces, the Worse the Prognosis Is: Semi-Quantitative Evaluation of Spread through Air Spaces in Pulmonary Adenocarcinomas. Pathobiology 90:104\u2013113. https:\/\/doi.org\/10.1159\/000525456","journal-title":"Pathobiology"},{"key":"4707_CR47","doi-asserted-by":"publisher","unstructured":"Jia, Jia M, Yu S, Yu J, Li Y, Gao H, Sun PL (2020) (2020) Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC\/UICC staging system. BMC Cancer 20:705. https:\/\/doi.org\/10.1186\/s12885-020-07200-w","DOI":"10.1186\/s12885-020-07200-w"},{"key":"4707_CR48","doi-asserted-by":"publisher","unstructured":"Lee, Lee JS, Kim EK, Kim M, Shim HS (2018) (2018) Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces. Lung Cancer 123:121\u2013126. https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.020","DOI":"10.1016\/j.lungcan.2018.07.020"},{"key":"4707_CR49","doi-asserted-by":"publisher","unstructured":"Zhang, Zhang Z, Liu Z, Feng H, Xiao F, Shao W, Liang C, Sun H, Gu X, Liu D (2020) (2020) Predictive value of radiological features on spread through air space in stage cIA lung adenocarcinoma. J Thorac Dis 12:6494\u20136504. https:\/\/doi.org\/10.21037\/jtd-20-1820","DOI":"10.21037\/jtd-20-1820"},{"key":"4707_CR50","doi-asserted-by":"publisher","unstructured":"Toyokawa, Toyokawa G, Yamada Y, Tagawa T, Oda Y (2018) (2018) Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection. Thorac Cancer 9:1255\u20131261. https:\/\/doi.org\/10.1111\/1759-7714.12828","DOI":"10.1111\/1759-7714.12828"},{"key":"4707_CR51","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.2147\/CMAR.S266750","volume":"12","author":"Q Zeng","year":"2020","unstructured":"Zeng2020, Zeng Q, Wang B, Li J, Zhao J, Mao Y, Gao Y, Xue Q, Gao S, Sun N, He J (2020) Solid Nodule Appearance as a Predictor of Tumor Spread Through Air Spaces in Patients with Lung Adenocarcinoma: A Propensity Score Matching Study. Cancer Manag Res 12:8197\u20138207. https:\/\/doi.org\/10.2147\/CMAR.S266750","journal-title":"Cancer Manag Res"},{"key":"4707_CR52","doi-asserted-by":"publisher","first-page":"1101443","DOI":"10.3389\/fgene.2023.1101443","volume":"14","author":"R Ye","year":"2023","unstructured":"Ye2023, Ye R, Yu Y, Zhao R, Han Y, Lu S (2023) Comprehensive molecular characterizations of stage I-III lung adenocarcinoma with tumor spread through air spaces. Front Genet 14:1101443. https:\/\/doi.org\/10.3389\/fgene.2023.1101443","journal-title":"Front Genet"},{"key":"4707_CR53","unstructured":"Nicholson AG, Butnor KJ, Calabrese F et al (2023) Lung Cancer Histopathology Reporting Guide. 4th edition. International Collaboration on Cancer Reporting, Sydney"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04707-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04707-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04707-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:11:33Z","timestamp":1788268293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04707-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":53,"alternative-id":["4707"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04707-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Institutional Ethical Committee (Albert Szent-Gy\u00f6rgyi Clinical Centre of the University of Szeged) (approval number\/protocol number 224\/SZTE RKEB\/2025).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}